GlassScriptPhysician profile
Sarah Onan
NPI 1396105565
$2,523.94
in general payments reported to CMS, 2019-2025
23 companies · $385 in 2025
The $385 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $325 · 2021: $108 · 2022: $168 · 2023: $1,240 · 2024: $298 · 2025: $385.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,380 · Travel and Lodging: $520 · Gift: $22.84.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,380.26 |
| Travel and Lodging | $520.20 |
| Gift | $22.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $1,034.32 | 2023 | Da Vinci Surgical System |
| Medical Device Business Services, INC. | $325.00 | 2019 | |
| Biogen, INC. | $206.57 | 2024-2025 | Zurzuvae |
| Sumitomo Pharma America, INC. | $192.98 | 2023-2025 | Myfembree, Gemtesa |
| Mayne Pharma Commercial LLC | $95.63 | 2023-2025 | |
| Myovant Sciences INC. | $88.83 | 2021-2022 | |
| Sage Therapeutics, LLC | $76.77 | 2022-2023 | |
| Astellas Pharma US INC | $76.09 | 2023-2025 | Veozah |
| Organon LLC | $71.16 | 2021-2025 | Nexplanon |
| Agile Therapeutics, INC. | $62.38 | 2022-2024 | Twirla |
| Shield Therapeutics INC | $45.19 | 2024 | |
| Ethicon US, LLC | $34.44 | 2021 | |
| Applied Medical Resources Corporation | $27.01 | 2024 | |
| Coopersurgical, INC. | $23.38 | 2025 | Sos |
| Abbvie INC. | $23.27 | 2021 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gynesonics, INC. | $20.97 | 2024 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Daiichi Sankyo INC. | $20.08 | 2022 | |
| Glaxosmithkline, LLC. | $17.64 | 2024 | Shingrix, Arexvy |
| Hologic Sales and Service, LLC | $17.15 | 2025 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Novo Nordisk INC | $17.07 | 2025 | Wegovy |
| Pacira Pharmaceuticals Incorporated | $16.58 | 2023 | Iovera, Zilretta, Exparel |
| Bayer Healthcare Pharmaceuticals INC. | $15.86 | 2025 | |
| Pfizer INC. | $15.57 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sarah Onan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.